Abstract:We conducted functional screening for new miRNAs that can regulate the cellular response to hypoxia by determining the effect of each miRNA on the hypoxia-inducible factor-1 alpha (HIF-1α) expression after hypoxia exposure, using a miRNA mimic pool consisting of 267 species. Among the several HIF-1α-regulating miRNA candidates identified from the functional screening, miR-5586-5p was here characterized as a potent miRNA suppressing hypoxia-induced angiogenesis in breast cancer. The expression of the critical proangiogenic factors vascular endothelial growth factor A (VEGFA) and angiopoietin-like protein 4 (ANGPTL4) were inhibited by miR-5586-5p in breast cancer cells MDA-MB-231 and BT-549. Migration and tube formation of human umbilical vein endothelial cells (HUVEC) were reduced in the conditioned medium (CM) prepared from miR-5586-5p-transfected cells compared to those in the CM prepared from control cells. In addition to HIF-1α, miR-5586-5p also suppressed the expression of heparin-binding EGF-like growth factor (HBEGF) and a disintegrin and metalloprotease 17 (ADAM17), which are known to play a role in hypoxic signaling to induce the expressions of VEGFA and ANGPTL4. HIF-1α, HBEGF, and ADAM17 were verified as the direct targets of miR-5586-5p. Forced downregulation of HIF-1α, HBEGF, or ADAM17 phenocopied the angiogenesis-suppressing function of miR-5586-5p, while the ectopic expression of HIF-1α or HBEGF suppressed the function of miR-5586-5p. Expression levels of miR-5586-5p were lower in tumor tissues than in neighboring normal tissues of breast cancer patients. Inverse correlations of miR-5586-5p expression to those of HIF-1α, HBEGF, ADAM17, VEGFA, and ANGPTL4 were demonstrated both in tumor tissues and by using miR-5586-5p-monitoring reporter cells. In vivo study using orthotopic MDA-MB-231 xenografts in mice revealed that angiogenesis and subsequent tumor growth were suppressed by intratumoral injection of miR-5586-5p mimic. Taken together, our results suggest a novel tumor-suppressive function of miR-5586-5p and its promising applicability for the development of a novel cancer treatment strategy. Graphical abstract Download: Download high-res image (135KB) Download: Download full-size image

Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis.

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

Role of Specific Micrornas for Endothelial Function and Angiogenesis

MiR-29a modulates the angiogenic properties of human endothelial cells.

MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia

Hypoxia-inducible MiR-182 Promotes Angiogenesis by Targeting RASA1 in Hepatocellular Carcinoma.

Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

Global Microrna Depletion Suppresses Tumor Angiogenesis.

A positive feedback loop between miR-574-3p and HIF-1α in promoting angiogenesis under hypoxia

Hypoxia-induced Deregulation of Mir-126 and Its Regulative Effect on VEGF and MMP-9 Expression.

EGFR Modulates Microrna Maturation in Response to Hypoxia Through Phosphorylation of AGO2

Abstract 3980: Hypoxia-induced Microrna-424 Targets CUL2 to Stabilize HIF-α Isoforms and Promotes Angiogenesis

MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs

Unveiling the Regulatory Role of LncRNA MYU in Hypoxia-Induced Angiogenesis via the miR-23a-3p Axis in Endothelial Cells

MicroRNA-210-3p Targets RGMA to Enhance the Angiogenic Functions of Endothelial Progenitor Cells under Hypoxic Conditions

Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6.

MicroRNA-503 Targets FGF2 and VEGFA and Inhibits Tumor Angiogenesis and Growth.

Mirna-Dependent Cross-Talk Between VEGF and Ang-2 in Hypoxia-Induced Microvascular Dysfunction.

miR-5586-5p suppresses hypoxia-induced angiogenesis through multiple targeting of HIF-1α, HBEGF, and ADAM17 in breast cancer